Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Dazheng Group persists in Hollysys takeover bid at $29.50 per share

Published 2024-02-04, 09:08 a/m
Updated 2024-02-04, 09:08 a/m
© Reuters.

HONG KONG - A consortium led by Dazheng Group Acquisition Limited has reaffirmed its intention to acquire Hollysys Automation (NASDAQ:HOLI) Technologies Ltd. (NASDAQ: HOLI), offering shareholders a premium over the competing Ascendent Capital bid. The consortium's unwavering offer of $29.50 per share stands as an 11.3% premium to Ascendent's proposal, aiming to provide Hollysys shareholders with a more assured closing.

The consortium, which includes Dazheng Group and TFI Asset Management Limited, has secured financial commitments that surpass industry norms, with a $1.05 billion debt commitment from a prominent PRC-headquartered bank and $800 million in equity commitments. These commitments are backed by robust proof of funding, including bank statements and formally executed equity commitment letters, providing a closing certainty that the consortium claims is superior to that of Ascendent's offer.

Negotiations between Hollysys and the consortium began on January 28, 2024, as acknowledged by the Special Committee in a proxy statement supplement. The consortium argues that the Special Committee's recognition of their proposal implies its superiority or potential superiority over Ascendent's bid. However, the Special Committee has not recommended an adjournment of the Extraordinary General Meeting (EGM) scheduled for February 8, 2024, to consider the consortium's offer. As a result, the consortium is urging shareholders to vote AGAINST the Ascendent transaction to secure the possibility of exiting at $29.50 per share.

Leading Proxy Advisors, Institutional Shareholder Services (ISS) and Glass Lewis, have recommended that shareholders vote against the Ascendent transaction, citing concerns over the sales process and the Special Committee's actions. The consortium emphasizes that rejection of the Ascendent deal would not incur a termination fee for Hollysys and maintains that a vote against it is in the shareholders' best interest.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The consortium has also highlighted the importance of not voting for the Ascendent transaction to preserve dissenting and appraisal rights under Section 179 of the British Virgin Islands Business Companies Act. This reminder comes in light of the lack of information on these rights in Hollysys's proxy statement.

This news is based on a press release statement from Dazheng Group Acquisition Limited.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.